Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Czerny, M; Funovics, M; Sodeck, G; Dumfarth, J; Schoder, M; Juraszek, A; Dziodzio, T; Zimpfer, D; Loewe, C; Lammer, J; Rosenhek, R; Ehrlich, M; Grimm, M.
Long-term results of thoracic endovascular aortic repair in atherosclerotic aneurysms involving the descending aorta.
J Thorac Cardiovasc Surg. 2010; 140(6 Suppl):S179-84; discussion S185-S190 Doi: 10.1016/j.jtcvs.2010.06.031
Web of Science PubMed FullText FullText_MUG

Co-authors Med Uni Graz: Zimpfer Daniel
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: OBJECTIVE: This study evaluated long-term results of thoracic endovascular aortic repair for atherosclerotic aneurysms involving descending aorta. METHODS: One hundred thirteen patients underwent thoracic endovascular aortic repair for this indication from 1996 to 2009. Mean follow-up was 54 ± 38 months (5-144 months). In-hospital mortality, neurologic injury, need for rerouting, occurrence of endoleaks and their treatment, and survival were recorded. RESULTS: In-hospital mortality was 5.3%. Transient neurologic injury rate was 2.6%. Previous rerouting was performed in 51%. Assisted early and late type I and III endoleak rates were 7.9% and 5.7%, respectively. Five percent of patients required late surgical conversion. Actuarial survivals were 86%, 60%, and 42% at 1, 5, and 10 years, respectively. Aorta-related actuarial survivals were 94%, 90%, and 83% at 1, 5, and 10 years, respectively. Cox regression analysis revealed higher number of prostheses as independent risk factor for early (hazard ratio, 5.38; 95% confidence interval, 1.68-42.37) and late (hazard ratio, 8.49; 95% confidence interval, 1.09-66.06) endoleak formation. Female sex (hazard ratio, 0.35; 95% confidence interval, 0.13-0.99), no arch involvement (hazard ratio, 0.21; 95% confidence interval, 0.05-0.08), and higher number of prostheses (hazard ratio, 7.95; 95% confidence interval, 1.36-46.58) affected survival. CONCLUSIONS: Aorta-related survival is excellent among patients undergoing thoracic endovascular aortic repair for atherosclerotic aneurysms involving the descending aorta. Life-long surveillance remains mandatory, with early and late failure uncommon but still needing consideration. Thoracic endovascular aortic repair in this group of patients remains attractive and has now proven durability.
Find related publications in this database (using NLM MeSH Indexing): Aged - administration & dosage; Aortic Aneurysm, Thoracic - etiology, mortality, surgery; Atherosclerosis - complications; Austria - administration & dosage; Blood Vessel Prosthesis Implantation - adverse effects, mortality; Chi-Square Distribution - administration & dosage; Endoleak - etiology; Endovascular Procedures - adverse effects, mortality; Female - administration & dosage; Hospital Mortality - administration & dosage; Humans - administration & dosage; Kaplan-Meier Estimate - administration & dosage; Male - administration & dosage; Proportional Hazards Models - administration & dosage; Reoperation - administration & dosage; Risk Assessment - administration & dosage; Risk Factors - administration & dosage; Survival Analysis - administration & dosage; Time Factors - administration & dosage; Trauma, Nervous System - etiology; Treatment Outcome - administration & dosage